RELIEF THERAPEUTICS (UK) Analysis
| 0QKQ Stock | 2.23 0.06 2.76% |
RELIEF THERAPEUTICS Holding is overvalued with Real Value of 2.06 and Hype Value of 2.23. The main objective of RELIEF THERAPEUTICS stock analysis is to determine its intrinsic value, which is an estimate of what RELIEF THERAPEUTICS Holding is worth, separate from its market price. There are two main types of RELIEF THERAPEUTICS's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect RELIEF THERAPEUTICS's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of RELIEF THERAPEUTICS's stock to identify patterns and trends that may indicate its future price movements.
The RELIEF THERAPEUTICS stock is traded in UK on London Exchange, with the market opening at 08:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in UK. RELIEF THERAPEUTICS is usually not traded on Good Friday, Easter Monday, May Day Bank Holiday, Spring Bank Holiday ( 2025 ), Summer Bank Holiday, Christmas Day, Boxing Day, New Year 's Day. RELIEF Stock trading window is adjusted to Europe/London timezone.
RELIEF |
RELIEF Stock Analysis Notes
About 23.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 0.01. RELIEF THERAPEUTICS had not issued any dividends in recent years. The entity had 0.0025:1 split on the 5th of May 2023. For more info on RELIEF THERAPEUTICS Holding please contact the company at 41 44 723 59 59 or go to https://www.relieftherapeutics.com.RELIEF THERAPEUTICS Investment Alerts
| RELIEF THERAPEUTICS had very high historical volatility over the last 90 days | |
| RELIEF THERAPEUTICS has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 8.42 M. Net Loss for the year was (17.12 M) with profit before overhead, payroll, taxes, and interest of 5.84 M. | |
| RELIEF THERAPEUTICS generates negative cash flow from operations |
RELIEF Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.41 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate RELIEF THERAPEUTICS's market, we take the total number of its shares issued and multiply it by RELIEF THERAPEUTICS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.RELIEF Profitablity
RELIEF THERAPEUTICS's profitability indicators refer to fundamental financial ratios that showcase RELIEF THERAPEUTICS's ability to generate income relative to its revenue or operating costs. If, let's say, RELIEF THERAPEUTICS is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, RELIEF THERAPEUTICS's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of RELIEF THERAPEUTICS's profitability requires more research than a typical breakdown of RELIEF THERAPEUTICS's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (2.03) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.27) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.27. Management Efficiency
RELIEF THERAPEUTICS has return on total asset (ROA) of (0.0735) % which means that it has lost $0.0735 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3852) %, meaning that it generated substantial loss on money invested by shareholders. RELIEF THERAPEUTICS's management efficiency ratios could be used to measure how well RELIEF THERAPEUTICS manages its routine affairs as well as how well it operates its assets and liabilities. At this time, RELIEF THERAPEUTICS's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 56.4 M in 2025, whereas Total Current Assets are likely to drop slightly above 15.7 M in 2025.Leadership effectiveness at RELIEF THERAPEUTICS Holding is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 20th of July, RELIEF THERAPEUTICS holds the semi deviation of 4.75, and Risk Adjusted Performance of 0.0235. RELIEF THERAPEUTICS technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Please check RELIEF THERAPEUTICS coefficient of variation, variance, and the relationship between the downside deviation and standard deviation to decide if RELIEF THERAPEUTICS is priced more or less accurately, providing market reflects its current price of 2.23 per share.RELIEF THERAPEUTICS Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Simple Moving Average indicator is calculated by adding the closing price of RELIEF THERAPEUTICS for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out RELIEF THERAPEUTICS short-term fluctuations and highlight longer-term trends or cycles.
RELIEF THERAPEUTICS Predictive Daily Indicators
RELIEF THERAPEUTICS intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of RELIEF THERAPEUTICS stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
RELIEF THERAPEUTICS Forecast Models
RELIEF THERAPEUTICS's time-series forecasting models are one of many RELIEF THERAPEUTICS's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary RELIEF THERAPEUTICS's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About RELIEF Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how RELIEF THERAPEUTICS prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling RELIEF shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as RELIEF THERAPEUTICS. By using and applying RELIEF Stock analysis, traders can create a robust methodology for identifying RELIEF entry and exit points for their positions.
RELIEF THERAPEUTICS is entity of United Kingdom. It is traded as Stock on LSE exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding RELIEF THERAPEUTICS to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Additional Tools for RELIEF Stock Analysis
When running RELIEF THERAPEUTICS's price analysis, check to measure RELIEF THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RELIEF THERAPEUTICS is operating at the current time. Most of RELIEF THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of RELIEF THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RELIEF THERAPEUTICS's price. Additionally, you may evaluate how the addition of RELIEF THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.